{"entity":{"type":"insider","cik":"0001752139","url":"/insider/0001752139","json_url":"/insider/0001752139.json","name":"Becker Daniel J.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":10,"first":"2018-09-20","last":"2024-07-19","span_basis":"filed_date"},"name_variants":[{"name":"Becker Daniel J.","source":"filing","n_filings":10,"first_seen":"2018-09-20","last_seen":"2024-07-19"}],"transactions":[{"id":3274076,"accession":"0001962918-24-000099","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001962918-24-000099","line_url":"/filing/0001962918-24-000099#line-1","is_derivative":false,"issuer_cik":"0001752139","issuer_name":"ACELYRIN, Inc.","issuer_ticker":"SLRN","issuer_name_source":null,"issuer_url":"/issuer/0001752139","owner_cik":"0001752139","owner_name":"Becker Daniel J.","owner_display_name":"Becker Daniel J.","owner_url":"/insider/0001752139","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1.0,"shares_display":"1","price_per_share":6.86,"price_display":"6.86","price_state":"stated","total_value":6.86,"total_display":"6.86","total_whole":"7","shares_owned_after":2999.0,"shares_owned_after_display":"2,999","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-17","filed_date":"2024-07-19","scope":"insider"},{"id":8220260,"accession":"0001209191-23-028874","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-028874","line_url":"/filing/0001209191-23-028874#line-1","is_derivative":false,"issuer_cik":"0001752139","issuer_name":"ACELYRIN, Inc.","issuer_ticker":"SLRN","issuer_name_source":null,"issuer_url":"/issuer/0001752139","owner_cik":"0001752139","owner_name":"Becker Daniel J.","owner_display_name":"Becker Daniel J.","owner_url":"/insider/0001752139","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":54000.0,"total_display":"54,000.00","total_whole":"54,000","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-09","filed_date":"2023-05-11","scope":"insider"},{"id":4837269,"accession":"0001209191-21-037023","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-037023","line_url":"/filing/0001209191-21-037023#line-1","is_derivative":false,"issuer_cik":"0001752139","issuer_name":"Day One Biopharmaceuticals, Inc.","issuer_ticker":"DAWN","issuer_name_source":null,"issuer_url":"/issuer/0001752139","owner_cik":"0001752139","owner_name":"Becker Daniel J.","owner_display_name":"Becker Daniel J.","owner_url":"/insider/0001752139","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":80000.0,"total_display":"80,000.00","total_whole":"80,000","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-01","filed_date":"2021-06-01","scope":"insider"},{"id":2208682,"accession":"0000899243-20-031941","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-031941","line_url":"/filing/0000899243-20-031941#line-1","is_derivative":false,"issuer_cik":"0001752139","issuer_name":"Pandion Therapeutics, Inc.","issuer_ticker":"PAND","issuer_name_source":null,"issuer_url":"/issuer/0001752139","owner_cik":"0001752139","owner_name":"Becker Daniel J.","owner_display_name":"Becker Daniel J.","owner_url":"/insider/0001752139","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":197716.0,"shares_display":"197,716","price_per_share":15.12,"price_display":"15.12","price_state":"stated","total_value":2989465.92,"total_display":"2,989,465.92","total_whole":"2,989,466","shares_owned_after":2827883.0,"shares_owned_after_display":"2,827,883","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-19","filed_date":"2020-11-23","scope":"insider"},{"id":2329650,"accession":"0000899243-20-031744","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-031744","line_url":"/filing/0000899243-20-031744#line-3","is_derivative":false,"issuer_cik":"0001752139","issuer_name":"Pandion Therapeutics, Inc.","issuer_ticker":"PAND","issuer_name_source":null,"issuer_url":"/issuer/0001752139","owner_cik":"0001752139","owner_name":"Becker Daniel J.","owner_display_name":"Becker Daniel J.","owner_url":"/insider/0001752139","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14197.0,"shares_display":"14,197","price_per_share":15.26,"price_display":"15.26","price_state":"stated","total_value":216646.22,"total_display":"216,646.22","total_whole":"216,646","shares_owned_after":2630167.0,"shares_owned_after_display":"2,630,167","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-18","filed_date":"2020-11-19","scope":"insider"},{"id":2329645,"accession":"0000899243-20-031744","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-031744","line_url":"/filing/0000899243-20-031744","is_derivative":false,"issuer_cik":"0001752139","issuer_name":"Pandion Therapeutics, Inc.","issuer_ticker":"PAND","issuer_name_source":null,"issuer_url":"/issuer/0001752139","owner_cik":"0001752139","owner_name":"Becker Daniel J.","owner_display_name":"Becker Daniel J.","owner_url":"/insider/0001752139","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15197.0,"shares_display":"15,197","price_per_share":15.315766927683095,"price_display":"15.32","price_state":"stated","total_value":232753.71,"total_display":"232,753.71","total_whole":"232,754","shares_owned_after":2615970.0,"shares_owned_after_display":"2,615,970","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-17","filed_date":"2020-11-19","scope":"insider","n_lines":2},{"id":2507361,"accession":"0000899243-20-019874","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-019874","line_url":"/filing/0000899243-20-019874","is_derivative":false,"issuer_cik":"0001752139","issuer_name":"Pandion Therapeutics, Inc.","issuer_ticker":"PAND","issuer_name_source":null,"issuer_url":"/issuer/0001752139","owner_cik":"0001752139","owner_name":"Becker Daniel J.","owner_display_name":"Becker Daniel J.","owner_url":"/insider/0001752139","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":723222.0,"shares_display":"723,222","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":13017996.0,"total_display":"13,017,996.00","total_whole":"13,017,996","shares_owned_after":2600773.0,"shares_owned_after_display":"2,600,773","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-21","filed_date":"2020-07-21","scope":"insider","n_lines":2},{"id":8011107,"accession":"0001209191-19-057879","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-057879","line_url":"/filing/0001209191-19-057879#line-1","is_derivative":false,"issuer_cik":"0001510487","issuer_name":"Principia Biopharma Inc.","issuer_ticker":"PRNB","issuer_name_source":null,"issuer_url":"/issuer/0001510487","owner_cik":"0001752139","owner_name":"Becker Daniel J.","owner_display_name":"Becker Daniel J.","owner_url":"/insider/0001752139","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":55000.0,"shares_display":"55,000","price_per_share":29.94,"price_display":"29.94","price_state":"stated","total_value":1646700.0,"total_display":"1,646,700.00","total_whole":"1,646,700","shares_owned_after":667600.0,"shares_owned_after_display":"667,600","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-20","filed_date":"2019-11-22","scope":"insider"},{"id":7807029,"accession":"0001209191-19-054503","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-054503","line_url":"/filing/0001209191-19-054503#line-2","is_derivative":false,"issuer_cik":"0001510487","issuer_name":"Principia Biopharma Inc.","issuer_ticker":"PRNB","issuer_name_source":null,"issuer_url":"/issuer/0001510487","owner_cik":"0001752139","owner_name":"Becker Daniel J.","owner_display_name":"Becker Daniel J.","owner_url":"/insider/0001752139","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9196.0,"shares_display":"9,196","price_per_share":33.9797,"price_display":"33.98","price_state":"stated","total_value":312477.3212,"total_display":"312,477.32","total_whole":"312,477","shares_owned_after":612600.0,"shares_owned_after_display":"612,600","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-10-29","filed_date":"2019-10-30","scope":"insider"},{"id":7807025,"accession":"0001209191-19-054503","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-054503","line_url":"/filing/0001209191-19-054503#line-1","is_derivative":false,"issuer_cik":"0001510487","issuer_name":"Principia Biopharma Inc.","issuer_ticker":"PRNB","issuer_name_source":null,"issuer_url":"/issuer/0001510487","owner_cik":"0001752139","owner_name":"Becker Daniel J.","owner_display_name":"Becker Daniel J.","owner_url":"/insider/0001752139","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":68404.0,"shares_display":"68,404","price_per_share":33.4125,"price_display":"33.41","price_state":"stated","total_value":2285548.65,"total_display":"2,285,548.65","total_whole":"2,285,549","shares_owned_after":603404.0,"shares_owned_after_display":"603,404","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-10-28","filed_date":"2019-10-30","scope":"insider"},{"id":8102660,"accession":"0001209191-19-053770","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-053770","line_url":"/filing/0001209191-19-053770#line-1","is_derivative":false,"issuer_cik":"0001510487","issuer_name":"Principia Biopharma Inc.","issuer_ticker":"PRNB","issuer_name_source":null,"issuer_url":"/issuer/0001510487","owner_cik":"0001752139","owner_name":"Becker Daniel J.","owner_display_name":"Becker Daniel J.","owner_url":"/insider/0001752139","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":535000.0,"shares_display":"535,000","price_per_share":28.0,"price_display":"28.00","price_state":"stated","total_value":14980000.0,"total_display":"14,980,000.00","total_whole":"14,980,000","shares_owned_after":535000.0,"shares_owned_after_display":"535,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-10-18","filed_date":"2019-10-22","scope":"insider"},{"id":6498364,"accession":"0001209191-18-051835","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-18-051835","line_url":"/filing/0001209191-18-051835#line-6","is_derivative":false,"issuer_cik":"0001510487","issuer_name":"Principia Biopharma Inc.","issuer_ticker":"PRNB","issuer_name_source":null,"issuer_url":"/issuer/0001510487","owner_cik":"0001752139","owner_name":"Becker Daniel J.","owner_display_name":"Becker Daniel J.","owner_url":"/insider/0001752139","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":270000.0,"shares_display":"270,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":4590000.0,"total_display":"4,590,000.00","total_whole":"4,590,000","shares_owned_after":437537.0,"shares_owned_after_display":"437,537","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-09-18","filed_date":"2018-09-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":13,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001962918","name":"ACELYRIN, Inc.","url":"/issuer/0001962918","role":"Director","n_filings":2,"first_seen":"2023-05-11","last_seen":"2024-07-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001845337","name":"Day One Biopharmaceuticals, Inc.","url":"/issuer/0001845337","role":"Director","n_filings":1,"first_seen":"2021-06-01","last_seen":"2021-06-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001807901","name":"Pandion Therapeutics, Inc.","url":"/issuer/0001807901","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2020-07-21","last_seen":"2020-11-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001510487","name":"Principia Biopharma Inc.","url":"/issuer/0001510487","role":"Director, Ten percent owner","n_filings":4,"first_seen":"2018-09-20","last_seen":"2019-11-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001752139","retrieved_at":"2026-08-22T06:31:21+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}